Bridges Investment Management Inc Eli Lilly & CO Transaction History

Bridges Investment Management Inc

$6.51 Billion
Q2 2024

A detailed history of Bridges Investment Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Bridges Investment Management Inc holds 11,361 shares of LLY stock, worth $10.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

11,361

Previous 9,925 14.47%

Holding current value

$10.5 Million

Previous $7.72 Million 33.22%

% of portfolio

0.16%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $1.04 Million - $1.31 Million	1,436 Added 14.47%	11,361 $10.3 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $24,872 - $33,275	-42 Reduced 0.42%	9,925 $7.72 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $30,986 - $36,528	-59 Reduced 0.59%	9,967 $5.81 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $13,041 - $17,979	-30 Reduced 0.3%	10,026 $5.39 Million
Q2 2023 Jul 07, 2023	SELL	$350.74 - $468.98 $20,342 - $27,200	-58 Reduced 0.57%	10,056 $4.72 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $15,531 - $18,241	-50 Reduced 0.49%	10,114 $3.47 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $16,077 - $18,733	-50 Reduced 0.49%	10,164 $3.72 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $133,119 - $151,703	-449 Reduced 4.21%	10,214 $3.3 Million
Q1 2022 Apr 08, 2022	SELL	$234.69 - $291.66 $29,336 - $36,457	-125 Reduced 1.16%	10,663 $3.05 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $16,863 - $20,928	75 Added 0.7%	10,788 $2.98 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $68,031 - $83,721	-307 Reduced 2.79%	10,713 $2.48 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2,609 - $3,452	-20 Reduced 0.18%	11,020 $1.86 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $22,225 - $25,707	-152 Reduced 1.36%	11,040 $1.63 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $14,596 - $17,567	107 Added 0.97%	11,192 $1.84 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $29,524 - $36,542	-248 Reduced 2.19%	11,085 $1.54 Million
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $160,380 - $198,645	1,500 Added 15.25%	11,333 $1.49 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $53,395 - $58,080	-500 Reduced 4.84%	9,833 $1.1 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $14,624 - $17,070	-132 Reduced 1.26%	10,333 $1.15 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $111,618 - $139,503	-1,300 Reduced 11.05%	10,465 $1.12 Million
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $151,400 - $173,760	2,000 Added 20.48%	11,765 $1 Million
Q1 2018 Apr 25, 2018	BUY	$74.21 - $87.6 $509,600 - $601,549	6,867 Added 236.96%	9,765 $756,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $32,776 - $35,156	400 Added 16.01%	2,898 $244,000
Q3 2017 Oct 05, 2017	BUY	$77.07 - $85.54 $192,520 - $213,678	2,498	2,498 $214,000

Others Institutions Holding LLY

# of Institutions

3,868

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $878B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.

Account

Bridges Investment Management Inc Eli Lilly & CO Transaction History